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Abstract
The pharmaceutical industry is in the midst of a fundamental transformation. Institutional
regulations that have been in place for decades are being removed and competitive
pressures force pharmaceutical companies to adopt customer-oriented strategies.
Information technology which has traditionally been applied to many processes in this
industry is an important enabler for the interaction with key customer segments such as
physicians and patients. However, developing and transforming customer relationships is
merely a technological undertaking. Changes are required regarding strategy, processes
as well as the systems architecture. To develop an integrated customer relationship
management strategy this research draws on elements from established business
redesign. The emphasis is on portals that bundle services for the patient’s and
physician’s customer processes. This architecture framework has been elaborated in
cooperation with nine companies and applied at a major pharmaceutical company.

1.

Introduction

1.1

Information Technology in the Pharma Industry

The pharma(ceutical) industry is currently undergoing a period of fundamental change.
Structural changes, such as the direct sale of prescription drugs, increasingly wellinformed patients, the growing number of cost reductions of governments and health
insurance providers as well as new Internet-based initiatives have significant impact on a
pharma company’s relationships with its customers. In this competitive market
environment developing and selling high volume products (‘blockbusters’) to physicians,
hospitals, and wholesalers is simply no longer sufficient. Like in other industries
increasing customer retention by expanding and personalizing the services offered to
customers becomes a strategic imperative. Compared to the banking or high tech sector,
pharma companies still have a strong focus on their products and are only at the
beginning of systematically managing relationships to customers [35]. Kalustian et al.
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[18, 64] observed that customer relationship management (CRM) “has become a pharma
buzzword, but few companies actually practice it.” Among the goals of CRM are to
enhance the intensity of interaction with customers across one or more touch points and
to establish a uniform view on customer data [14, 81], [16, 31]. This helps to address
attractive customers, to decrease the cost of serving customers, and to increase customer
retention by providing tailored offerings to existing and new customers [33, 102].
Although pharma companies are not at the forefront of adopting CRM systems,
information technology (IT) the industry has pioneered many customer oriented
applications of IT in the past. First, interorganizational information systems (IOS)
improved the relationships to professional customers and well known examples for the
strategic use of IT such as the ordering systems from Baxter (formerly American Hospital
Supply) and McKesson originate from this industry [20, 209]. Secondly, hospitals are
operating internal systems to improve the healthcare process, e.g. administrative systems,
telemedicine, patient records [32]. Devaraj/Kohli report that IT-enabled business process
redesign initiatives from hospitals had a positive impact on the satisfaction of their
patients [11, 62]. Thirdly, the advent of the Internet more brought more circulation of
product and disease information to customers, the support of campaigns and clinical
trials, and the possibility of providing more value added to customers [22, 102]. The
buzzwords e-health and e-healthcare refer to the application of Internet technology to
pharma processes [9, 207] and the entire online drug industry is expected to grow
significantly in the long-term last but not least due to the IT-affinity and the increasing
role of healthcare to the ‘baby boomers’ [37, 445].
1.2

Goal of Paper and Research Methodology

The IT-driven transformation in the pharma industry creates strategic opportunities and
competitive pressures at the same time. On the one hand, existing and new players are
developing websites and portals for customer interaction as well as for enhanced quality
of care [19]. On the other hand, the Internet creates opportunities for pharma companies
to improve the depth and/or breadth of interaction with existing and new customer
segments. Both effects emphasize Porter’s view that Internet technologies are
complementary to existing interaction channels (e.g. sales force, call centers) and need to
leverage a company’s existing competencies [31]. Therefore, pharma companies are
forced to assess their existing strategies and to (re)position themselves. It is the goal of
this paper to present a framework for understanding the changes and for developing
solutions for electronic customer interaction for a pharma company.
CRM systems from Siebel, SAP and others are key enablers for CRM strategies as they
provide a consistent and consolidated customer database, electronic support for customer
interactions, and sophisticated analytical tools. However, CRM projects are merely
technological. Studies show that the organization around the customer, the prototyping of
new (electronic) processes, and cultural factors determine CRM adoption [39, 205], [42,
18]. Business process redesign (BPR) methodologies such as business engineering
recognize the process as the link between strategy and systems development [28, 20].
However, these BPR methods have mainly been applied to processes within organizations
and are not focused on shaping customer-oriented solutions.
In cooperation with nine international companies an architecture framework has been
developed between 2000 and 2002 for customer and supplier interaction. Based on
individual research projects with each company, the research team drafted an architecture
which was subsequently refined in several workshops with representatives of the partner

523

Rainer Alt

companies.1 In applying the architecture at Pharma Corp, one of the largest pharma
companies worldwide, this research follows the tradition of action research where the
researcher is directly involved in the project work [38, 20].

2.

Transformation of Downstream Processes

2.1

Challenges for Pharmaceutical Companies

Currently, a variety of changes is taking place which influence a pharma company’s
downstream (or customer facing) relationships. Innovations in R&D and CRM are seen as
the main areas of action for pharma companies [8]. While the former are an established
research topic addressing product innovation, the latter is a young field in the pharma
industry. Considering that over 110 million people are estimated to look for health-related
online information each month in the US alone, the Internet has significant potential [44].
Among the major challenges for CRM are:

1

•

Demanding healthcare customers. More competition increases the negotiation
power of patients who demand more value at lower prices and more freedom of
choice regarding healthcare providers [43, 9]. More active and informed patients
increasingly influence the choice of drugs and reduce the physician’s role as
decision-maker. Pharma companies need to include the specific requirements of
both patients and physicians in their strategies.

•

Restricted access to physicians. The number of visits of the pharma sales reps to
present products (‘detailing’) is set to decrease due to regulation in various
European countries and the doctors’ falling acceptance. At the same time, the
number of sales reps in the 40 largest pharma companies has doubled while
prescriptions have only grown by 15% [3, 256]. Pharma companies not only need
more efficiency in their sales force, but also must exploit new interaction
channels with this key customer segment.

•

Increasing cost pressure. To contain health costs, governments are exerting
increasing pressure on the prices of pharma companies. At the same time, parallel
imports from low-cost countries and the growing competition from generic drug
manufacturers are eroding margins. Many pharmaceutical companies have
therefore decided to optimize their sales strategies by introducing key account
management structures [30].

•

Declining regulation. Council Directive 92/28/EEC of March 31, 1992, for
example, prohibits the advertising of medical products for human use among end
users in the European Union. The US removed these restrictions in 1997 and
similar developments are now expected for Europe [5, 62]. Pharma companies
need to include direct sales and marketing in their strategies since online
pharmacies, procurement platforms or health portals may intermediate the
pharma company’s customer access [24].

For more information on this multilateral research design see [1, 11].
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2.2

Potentials of CRM

Xu et al. define CRM as an “all-embracing approach, which seamlessly integrates sales,
customer service, marketing, field support, and other functions that touch customers” [41,
442]. By systematically collecting and analyzing information on customer contacts CRM
aims to maximize the lifetime customer value [40, 94]. In the pharma industry multichannel CRM approaches are suggested which integrate traditional sales force and
Internet-based channels (eCRM) [15]. These will lead to improvements in three areas:
•

Market or customer segmentation is the basis for differentiated customer service
[25, 378] and recognizes that neither patients nor physicians are homogeneous in
their requirements. For example, opinion leaders can be segmented in four
different physician types [21, 165] and patients depending on their disease.
Patients with chronical diseases are long-term patients who invest time in
understanding their disease as well as possible medication alternatives. Patients
with acute diseases are often only interested in standard information on
combating symptoms to overcome their disease. CRM should also aim at
expanding the needs of this segment, e.g. from short-term illness to long-term
wellness [10, 8].

•

Based on a fine-grained segmentation pharma companies are able to offer value
added services that go beyond the selling of drugs and ‘blockbusters’2. These
services support the specific customer segments in all stages of their life cycle.
For example, chronical bronchitis patients could be provided in-depth
information on cortisone and antibiotics as well as various drugs which are
necessary during the course of their illness. Patients with acute diseases could be
offered standard drug information to combat high temperatures, chest pains or
coughing and general prevention advice.

•

Cross-/Up-selling are one outcome of integrated customer knowledge across a
pharma company’s divisions, such as diagnostics and pharmaceuticals. For
example, a physician who works with diabetes patients and uses a pharma
company’s equipment for blood analysis can also be offered drugs for preventing
weight problems (cross-selling). The same applies within individual product lines
to support sales of a higher-grade product (up-selling).

2.3

Limitations of Traditional Sales and Marketing

The present sales organization in many pharma companies is oriented towards three
customer segments: (1) physicians (2) hospitals, wholesalers and pharmacies, and (3) end
customers, i.e. patients [22, 101]. While computer manufacturers such as Dell deal with
the end customer direct, a pharma company’s main customers are physicians, pharmacies,
hospitals, and patients. For interaction with these customer groups, pharma companies
use different systems today:
•

2

Systems for Territory Management (TMS) or Sales Force Automation (SFA)
have been in operation for some time and support the sales force in visiting
physicians on a regular basis. A study conducted in Austria shows that good sales
reps still determine customer satisfaction and lead to indirect economic success
[34, 964].

Products with annual revenues of USD 500 million or more [10].
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•

KAM is an enhanced form of TMS, where dedicated key account managers look
after major customers such as hospitals, wholesalers, hospital buying syndicates
and other decision-makers.

•

Call centers and portal applications are emerging in certain countries for
physicians as well as for patients. Examples are portals for specific diseases (e.g.
oncology) or products (e.g. Aspirin). Patients are currently not addressed due to
regulation and complex relationships between end customers and the pharma
companies in Europe.

Wholesalers,
hospitals,
pharmacies
Territory
management
systems
(TMS)

Physicians

Internet portal

Key account
management

Call center

Business-to-Business

Business-to-Consumer

Figure 1 shows the evolution of these systems at Pharma Corp. Customer information is
neither systematically gathered and communicated between the local marketing divisions,
nor are interactions with customers on portals or call centers coordinated with the existing
KAM or TMS. This impedes to identify customer segments (e.g. chronically ill patients),
to develop the required additional services, and to use the potentials of up-/cross-selling.
Pharma Corp therefore decided to develop an integrated CRM architecture.

Patients

Integrated CRM-Architecture

Figure 1: Customer Segments and Channels in the Pharmaceutical Industry

3.

Development of a Customer-oriented Architecture

Architecture is an instrument for the systematic development of solutions in many areas
such as civil and systems engineering. In the latter it describes the integration of different
components to deliver one or more (technological) capabilities [36]. Although various ebusiness architecture frameworks have emerged (e.g. [12]) these are mainly technologydriven. In the following a top-down approach is described that encompasses three levels:
a business architecture which provides the frame for understanding the transformation of
the sales channels within the industry, a process architecture which develops the main
design elements for shaping customer-oriented services, and a systems architecture which
structures the supporting applications.
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3.1

Strategy: Business Architecture

3.1.1

Analysis of Downstream Actors and Relationships

On a strategic level customer orientation requires a sound understanding of the
downstream business network which depicts all actors involved [33, 102]. Figure 2
shows the existing business architecture with Pharma Corp’s marketing, sales and service
departments as well as the customer segments along the various interaction channels
(business-to-business, business-to-doctor, business-to-consumer, and business-togovernment).3 This structure represents the European market since the greatest changes
were expected here.

3
4

•

Physicians are the most important customers for pharma companies as they
possess the authority and the know-how to decide on the prescribed products.4
Nearly all academic physicians and a growing number of community physicians
are regularly using the Internet [27, xii]. Pharma companies strive to reduce the
current cost of EUR 1,000 per visit and to increase the length of each visit which
today takes only approx. nine minutes [17].

•

Although physicians make the product decision, patients are the final buyers of
pharma products [16, 32]. They are more likely to prepare themselves for
discussions with their doctors and have independently decided on their preferred
drug [23, 494]. Pharma companies aim at providing information which may
influence the choice of drugs.

•

Hospitals are high-volume customers for medicines. For example, the hospitals in
Switzerland purchased 20.7% of prescription medicines in 2000 [6]. Although
product decisions are still influenced by physicians, hospitals increasingly
employ professional procurement staff that exerts competitive pressures on
pharma companies.

•

Wholesalers are not regarded as customers but rather as a distribution channel. In
Switzerland the three largest wholesalers (Galenica, Amedis and Voigt ) together
command a 90% share of the market, while in most of Southern Europe the
market is still less concentrated. Consolidation is expected to increase, for
example, the three largest wholesalers already operate throughout Europe and
aim at downstream integration of pharmacies and hospitals.

•

Pharmacies sell drugs to patients on a prescription basis. In 2001 pharmacies sold
55.6% of all prescription drugs in Switzerland [6]. Pharmacies buy their drugs
from wholesalers and do not source direct from pharma companies.

•

Patient groups are interest groups who offer information and support regarding
specific illnesses. They influence politics and the pharma industry [7]. An interest
group, for example, was effective in securing approval of Herceptin (a drug used
against breast cancer) by promoting the drug to gain faster approval from the
food and drug administration (FDA) [2, 7]. Pharma companies aim at addressing
these patient groups with suitable services and information at the right moment in
time.

Since the business-to-government area does not have a direct impact on sales activities it is not analyzed here.
In the US 85% of all healthcare decisions are currently controlled by physicians [13].
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Pharma Corp
Wholesaler

Business-toBusiness

Pharmacy

Marketing
Hospital
Physician

Patient
(Interest group)

Sales
Physician
Business-to-Doctor

Business-to-Consumer

Service
Insurance company

Legend:

Goods flow

Information flow

Business-toGovernment

Authorities

Market participant

Figure 2: Traditional Business Architecture in the Pharma Industry
3.1.2

Transformation of Business Architecture

The Internet has spurred a variety of websites, portals and marketplaces which various
players in the downstream pharma network have used. Portals are websites that
personalize and integrate information on products and services from different vendors and
applications. While portals bundle information to provide a maximum coverage of
customer processes, marketplaces provide a transaction infrastructure among competing
suppliers using market mechanisms (e.g. auctions). Pharma companies have established
solutions to five customer segments (see 1 in Figure 3):
•

Patients receive information and services concerning diseases or therapies.
Among the examples are lillydirect.com for oncologists by Eli Lilly,
raacademy.com for patients with rheumatoid arthritis or ibreathe.com for asthma
patients by GlaxoSmithKline (see also [22, 102]).

•

Hospitals are offered catalogs for electronic procurement with multiple pharma
companies. To prevent hospitals from using order entry systems from various
pharma companies in parallel, marketplaces such as GHX have been established
in cooperation with competitors.5

•

Physicians obtain information on drugs, treatments, current research as well as
support in their operational processes and in training. Several companies have
started online and interactive product presentations to supplement or substitute
physical sales rep visits (‘eDetailing’) [3, 256], e.g. MyDoc Online from Aventis.

•

Pharmacies and wholesalers receive only little information from pharma
companies. The former are traditionally the wholesaler’s customers and the latter
have their own ordering systems in place.

Wholesaler portals (see area 2 in Figure 3) support electronic ordering and the purchase
of drugs between multiple pharma companies and pharmacies. Often they build upon a
wholesaler’s established electronic ordering system.
5

Founders of GHX are Johnson & Johnson, GE Medical Systems, Baxter, Abbott Laboratories, and Medtronic.
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Pharmacy portals emerged in two directions (see 3 in Figure 3). First, pharmacies
establish websites that include electronic chats with the pharmacist or ordering services
which enable patients to enter the required drug, fax the prescription and collect the
product in the physical store. Second, virtual pharmacies in the US and the UK offer
electronic catalogs, order entry and prescription handling. Among the remaining
examples are drugstore.com or cvs.com.6
Among the hospitals the medical schools are offering a wealth of medical information on
their websites. An analysis of the top fifty-one medical schools in the US showed that
especially the higher ranked schools had broad and deep information on diseases and
therapies etc. [44].
New information providers (see 4 in Figure 3) include telemedical services for
exchanging multimedia data (e.g. reports, x-rays, insurance number, etc.) between
physicians and patients [26]. Other portals provide in-depth knowledge on drugs and
healthcare (e.g. drkoop.com, webmd.com) or offer e-detailing services (e.g.
iPhysicianNet). To ensure the quality of medical information the Health on the Net
Foundation Code of Conduct (HONcode) was defined (see http://www.hon.ch).

Pharma Corp
Wholesaler

2

Pharmacy

2
Marketing

3
Business-toBusiness

1

Portal

Hospital

e.g. GHX

Patient
(Interest group)

Physician
1
Sales
Portal
e.g.
drkoop.com

4

Portal,
Physician

e.g.

4 Lifeline
Business-to-Consumer

Business-to-Doctor

Service
Insurance company

Legend:

Goods flow

Information flow

Business-toGovernment

Market participant

Authorities

Portal

Figure 3: Future Business Architecture in the Pharma Industry
When Pharma Corp evaluated the changes in their business architecture in 2001 they
decided to provide state-of-the-art regarding their websites (e.g. uniform layout
worldwide, consistent product information), to maintain parity in the area of online
pharmacies and downstream marketplaces (i.e. act upon strategic necessity), and to
develop competitive advantages by establishing portals for specific customer segments. In
a number of workshops with Pharma Corp’s country organizations, the existing and
expected importance of the customer segments was evaluated. As Figure 4 suggests,
patients and wholesalers should receive more attention in the future. However, physicians
still remain the most important segment for pharma companies.
6

For an overview on existing verified internet pharmacy practice sites (VIPPS) in the US see the National Association of
Boards of Pharmacy (http://www.nabp.net/vipps/consumer/listall.asp).
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Today
1

2

Future

Importance
3
4

5

1

2

Importance
3
4

5

Physicians
Patients
Hospitals
Wholesalers
Pharmacies
1 = Most important, 5 = Least important

Figure 4: Importance of Customer segments at Pharma Corp
3.2

Process Architecture

3.2.1

Customer Processes Analysis

On the process level Pharma Corp analyzed each customer segment to identify required
and valued services to be included in a portal. The customer process encompasses all
tasks which customers go through in order to satisfy their needs [29, 48]. Internal
workshops and customer surveys in six European countries with an average of ten sales
and marketing representatives were conducted. Three hospitals, two buying syndicates
and two wholesalers took part in the external survey. From this analysis the customer
processes as well as possible portal services were derived (see Figure 5):
•

The customer process of patients evolves around the prevention and treatment of
an illness. The sub-processes may differ in length and show that healthy persons
can also be customers of pharma companies (‘prevent’).

•

The physician’s process focuses on patient treatment, i.e. providing advice and
prescribing drugs. Included are knowledge management, i.e. systematic archiving
of information from medical journals or newsletters, professional development,
i.e. continuous medical education (CME) with online seminars etc. [4, 96],
patient data management, i.e. the storage of patient data and their medical
histories, and back-office, i.e. all administrative activities.

•

Hospital pharmacies have an emphasis on warehouse management. The
pharmacy manager’s process starts with observing medical developments and
searching information on sales figures, approval requirements and side effects of
drugs. After checking inventory and comparing terms of delivery, the hospital
pharmacist initiates a purchase order, the goods and the invoice are checked upon
receipt, and the goods are assigned to the warehouse.

•

Compared to hospital pharmacies, ‘independent’ pharmacies are more sales- than
logistics-driven. Dispensing drugs and advising customers is important here.
Necessary support processes are prescription handling and ordering.
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Micro-processes and portal services
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• Collaborative
planning and
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• Marketplace

Figure 5: Customer Processes with Portal Services at Pharma Corp
•

3.2.2

The wholesaler’s process resembles the hospital’s customer process. Purchasing
managers search for product information, new products on the market and data on
drugs such as the size of shipping units, the number of tablets or capsules per
pack. Terms such as payment and delivery dates are agreed with the pharma
companies depending on local reference prices.7
Portal Process Architecture

In a second step Pharma Corp developed the process architecture and analyzed how the
portal services were linked to the main CRM processes marketing, sales and service (see
Figure 6).
•

7

Marketing mainly provides services for pre-transaction activities. Pharma Corp’s
marketing is organized according to the therapeutic fields in which the company
is active. Although a distinction is made between the customer segments

In Germany, for example, a directive on the price of medicines regulates the price range between pharma companies and
wholesalers. Only discounts, terms of delivery and payment dates are freely negotiable.
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‘hospitals’ and ‘physicians’ at the top level, all activities one level further down
are directed at specific products. For a systematic evaluation of customer
contacts, an active communication to customers, and personalized marketing
campaigns, marketing defined all customer information to be collected by the
sales force.
•

Sales is also organized according to hospitals and physicians, and product lines at
the next level. To avoid that different sales reps visit the same customers, Pharma
Corp has appointed key account managers who are not responsible for the
success of an individual product but for success of certain customers. CRM
supports them with information across product lines.

•

Call centers are a major element in Pharma Corp’s service area. A single
telephone number (contact point) has been established for questions regarding
products. Calls are automatically routed to the person or department concerned,
depending on the call and the type of support required. CRM supports call center
staff with detailed, up-to-date customer information.

Pharma Corp

Customer

Portal

Marketing

Customer process
Patient

Self-care and
lifestyle info

Brand & customer
marketing

Prevent
Health
profiles

Sales

Feel unwell

Key account
management

Symptom
analysis

Fall ill

Territory
management
Expert consultation

Treat

eCommunity

Recover

Service
Call center

Business Collaboration Infrastructure
Business Process

Content & Transaction

Integration

IT-Operation

- Billing and payment

- Community management

- Content/Data accumulation

- Security (Authorization,

- Order tracking
- Cross- and upselling
- Customer profiling-

- Management reporting
- Product catalogs
- Question/Answer mgmt.

- Business directories
- Catalog management
- Subscriber registration

authentication)
- Webpage performance mgmt.
- Feasibility assessment

Figure 6: Portal Process Architecture for Customer Segment ‘Patients’
The portal architecture in Figure 6 also includes the services of external providers. These
electronic services offer specific highly standardized tasks which are charged on a time or
usage basis. They enable a pharma company to focus on critical areas and have emerged
for specific tasks in business processes, for horizontal tasks that may be applied in various
business processes (content & transaction services), for the consolidation, the unique
retrieval, and the automatic routing of information (integration services), as well as for
network operation (IT operation services) [29, 34]. Figure 7 shows examples which were
considered important for supporting the customer segments ‘patient’ and ‘physician’.
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Business process services
Online prescriptions,
www.rxhub.net
Appointment service
www.healinx.com
Immediate medical assistance
www.getwellness.ch
Online visit to the doctor’s
www.healinx.com
Professional training (x-rays)
www.yxlon.com
Online hospital registration
optimizer.sanalink.com
Continuous medical education
www.medscape.com
Content & transaction services
Health information
www.pharmavista.net
Discussion forums
www.getwellness.ch
Patient dossier exchange
optimizer.sanalink.com
Personal health data record
www.webmd.com
Self-care tips
www.webmd.com
Journal service
www.medscape.com
Communities
www.netdoktor.de
Drug catalog and warnings
www.drugstore.com
Drug check
www.gesundheitscout24.de
Integration services
Dictionaries of illnesses
www.medterms.com
Dictionary of drugs
www.medicineonline.com
Physician and therapist search
www.ama-assn.org/aps
Directories
www.medizin.ch
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Figure 7: Electronic Services for Patient and Physician Portals
These electronic services may also be pre-configured into a business collaboration
infrastructure offered by a third party provider such as global healthcare exchange
(GHX). At this moment, Pharma Corp is planning to integrate selected services
bilaterally. The criteria which have been used were strategic relevance (task is not core to
Pharma Corp’s business), cost (cost of service is below internal cost), and market power
(established player in the market / standard solution).
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3.2.3

System Architecture

The system architecture implements the process architecture regarding (1) the
applications which provide the functionality for the process portals and the CRM
processes, regarding (2) the integration solution which provides semantic and syntactical
compatibility for homogenized customer data, and regarding (3) the technical
infrastructure for the secure technical connectivity. Since the infrastructure architecture
uses standard Internet technology it is not elaborated here.
As a global company with strong local country divisions Pharma Corp decided to develop
a decentralized system architecture. To avoid incompatible customer data and the
implementation of multiple different systems, corporate guidelines determine the each
country’s configuration:
•

The application architecture which reflects the functional requirements in the
processes marketing (analytical and mailing functionalities), sales (functionalities
for planning and reporting of visits, expense, sample and congress management),
and service (functionalities for call centers, e.g. automatic call recognition). The
ERP application is used for product management, ordering, and sales; the CRM
application for call center, sales force, and marketing purposes.

•

The customer information platform (CIP) is a key element of the integration
architecture. CIP defines a customer data model and methods to integrate local
and corporate customer data. Both CRM and ERP supply and use data from the
CIP which consists of a data warehouse and master data management solution
(MDM). The data warehouse integrates data from various heterogeneous systems
and consolidates data for reporting purposes. MDM harmonizes the different field
names and customer ID numbers into a corporate standard.

•

The choice of system vendors which was limited to SAP in the ERP area and
Siebel or Update.com in the CRM area. While large countries use Siebel, smaller
countries use Update’s Marketing Manager. Other CRM systems will be
replaced. Standard configurations have also been developed for portals where a
solution from BEA/ATG has been selected.
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Figure 8: System Architecture at Pharma Corp
534

Transformation in the Pharmaceutical Industry – Developing Customer Orientation at Pharma Corp

4.

Summary and Outlook

Deregulation, cost pressures, and new Internet channels are forcing pharma companies to
adopt customer-oriented strategies and to reflect the sustainability of their existing
strategies. CRM systems and customer process portals are becoming strategic necessities
that determine customer retention as well as the operational efficiency of sales and
marketing processes. Pharma companies face transformations on three levels. The
business architecture supports the positioning regarding the target customer segments and
electronic intermediaries. The process architecture identifies customer processes for each
segment and derives portal services which can also be sourced from external service
providers. Finally, the system architecture reflects the organizational culture and enables
interoperability across heterogeneous applications. Pharma Corp estimates that the CRM
architecture leads to benefits in two areas.
•

CRM benefits. Since the implications of CRM on additional revenues are difficult
to quantify, Pharma Corp focused on the efficiency of sales and marketing
processes. For example, one branch office calculated an estimated increase in the
sales force headcount from 530 to 940 until 2005 due to the amount of new
products. CRM is expected to save approx. 190 of these additional sales reps
since only A and B customers will be visited regularly in future, while C and D
customers will be referred to the portals for product detailing. Besides manpower
cost such as expenses, samples, advertising material and tied-up assets (e.g.
laptops) are reduced. In another branch a more targeted communication with
customers reduced the sales rep workload for a single product line by approx.
25,000 visits (to physicians who never prescribe) per year (plus the associated
costs for advertising material, samples and expenses).

•

Architecture benefits. Among the typical benefits of architectures are reduced
redundancies which lead to reusable and interoperable solutions. For example,
pre-configured portals for physicians can be implemented in multiple country
organizations while development and maintenance skills are centralized in a
dedicated organization unit, the portal factory. Pharma Corp has accelerated the
portal development from previously 9-12 months to 2-3 months. Similar
synergies are expected for the implementation of the CRM standard solutions
Siebel and Update. Pharma Corp also expects that the architecture proves helpful
in evaluating, positioning, and integrating new technologies (e.g. mobile
technologies) at an early stage.

From a research perspective the presented architecture framework is only a first step
towards a systematic methodology for (re)engineering downstream relationships. This
includes techniques for developing result documents at each level of the architecture.
Further research is also necessary regarding the metrics for assessing the results of the
transformation which link the architecture to the business goals such as customer
orientation.
Acknowledgements
The author acknowledges and appreciates the work and the input of Thomas Puschmann,
Thomas Huber, and Roger Heutschi who were also involved in this project. This research
is part of the Competence Center for Business Networking (CC BN), a multilateral
research project within the research program Business Engineering HSG at the Institute
of Information Management, University of St. Gallen, Switzerland.
535

Rainer Alt

References
[1]

Alt, R., Fleisch, E., Österle, H., Introduction - Chances and Challenges in
Business Networking, in: Österle, H., Fleisch, E., Alt, R., Business Networking:
Shaping Collaboration Between Companies, Springer, Berlin etc., 2001, pp. 1-13

[2]

Anonymous, Pharma 2005: Marketing to the Individual, Pricewaterhouse
Coopers, 1999

[3]

Bates, A., Bailey, E., Rajyaguru, I., Navigating the e-Detailing Maze, in:
International Journal of Medical Marketing, 2 (2002) 3, pp. 255-262

[4]

Bleicher, P., Van Cleave, D., Beghiat, G., Ball, M., Pharma - Physician E-Hubs:
Online Communites Build Doctors' Loyalty, in: Pharmaceutical Executive, 20
(2000) 10, pp. 86-96

[5]

Breitstein, J., DTC in Europe?, in: Pharmaceutical Executive, 22 (2002) 1, pp.
62-63

[6]

Burckhardt, J., Engler, C., Salinas, L., Pharma-Markt Schweiz, Pharma
Information, Basel, 2001

[7]

Buttle, F., Boldrini, J., Customer Relationship Management in the Pharmaceutical
Industry: The Role of the Patient Advocacy Group, in: International Journal of
Medical Marketing, 1 (2001) 3, pp. 203-214

[8]

Challener, C., Customer Relationship Management and R&D Are Key for
Pharma Applications, in: Chemical Market Reporter, 258 (2000) 17, p. 19

[9]

Coile, R.C.J., E-Health: Reinventing Healthcare in the Information Age, in:
Journal of Healthcare Management, 45 (2000) 3, pp. 206-210

[10]

David, C., Marketing to the Consumer: Perspectives From the Pharmaceutical
Industry, in: Marketing Health Services, 21 (2001) 1, pp. 4-11

[11]

Devaraj, S., Kohli, R., Information Technology Payoff in the Health-Care
Industry: A Longitudinal Study, in: Journal of Management Information Systems,
16 (2000) 4, pp. 41-67

[12]

Fingar, P., Kumar, H., Sharma, T., Enterprise E-Commerce: The Software
Component Breakthrough for Business-to-Business Commerce, Meghan-Kiffer
Press, Tampa (FL), 2000

[13]

Fotsch, E., The Truth About E-Health, in: Pharmaceutical Executive, 22 (2002) 5,
pp. 112-116

[14]

Goodhue, D.L., Wixom, B.H., Watson, H.J., Realizing Business Benefits
Through CRM: Hitting the Right Target in the Right Way, in: MIS Quarterly
Executive, 1 (2002) 2, pp. 79-94

[15]

Hagemeier, D., The Case for Multichannel Pharmaceutical CRM, Gartner, 2002

[16]

Johnson, G., Kuman, A., Ramaprasad, A., Technology-Based Marketing in the
Healthcare Industry: Implications for Relationships Between Players in the
Industry, in: Eder, L.B. (Ed.), Managing Healthcare Information Systems with
Web-Enabled Technologies, Idea Group Publishing, Hershey/London, 2000, pp.
30-44

[17]

Junger, D., e-detailing: The Future of the Primary Care Salesforce?,
InPharm.com,
http://www.inpharm.com/netfocus/news/viewpoints/view_035.html, 20.04.
536

Transformation in the Pharmaceutical Industry – Developing Customer Orientation at Pharma Corp

[18]

Kalustian, J., Lombardi, B., Fletcher, W., CRM Checklist for Success, in:
Pharmaceutical Executive, 22 (2002) 2, pp. 64-66

[19]

Kerwin, K.E., The Role of the Internet in Improving Healthcare Quality, in:
Journal of Healthcare Management, 47 (2002) 4, pp. 225-236

[20]

Kim, K.K., Michelman, J.E., An Examination of Factors for the Strategic Use of
Information Systems in the Healthcare Industry, in: MIS Quarterly, 14 (1990) 2,
pp. 201-215

[21]

Lerer, L., Pharmaceutical Marketing Segmentation in the Age of the Internet, in:
International Journal of Medical Marketing, 2 (2002) 2, pp. 159-166

[22]

Lin, B., Huarng, F., Internet in the Pharmaceutical Industry: Infrastructure Issues,
in: American Business Review, 18 (2000) 1, pp. 101-106

[23]

Maddox, L.M., The Use of Pharmaceutical Web Sites for Prescription Drug
Information and Product Requests, in: Journal of Product & Brand Management,
8 (1999) 6, pp. 488-496

[24]

Martin, S., Yen, D.C., Tan, J.K., E-health: Impacts of Internet Technologies on
Various Healthcare and Services Sectors, in: International Journal of Healthcare
Technology & Management, 4 (2002) 1/2, pp. 71-86

[25]

Nairn, A., CRM: Helpful or Full of Hype?, in: Journal of Database Marketing, 9
(2002) 4, pp. 376-382

[26]

Nevins, R.L., Pion, R.J., Telemedicine Becomes a Reality With Web-Enabled
Applications and Net Devices, in: Goldstein, D.E. (Ed.), E-Healthcare - Harness
the Power of Internet e-Commerce & e-Care, Aspen Publishers, Maryland, 2000,
pp. 189-210

[27]

Nicholson, L., The Internet and Healthcare, Health Administration Press,
Chicago, 1999

[28]

Österle, H., Business in the Information Age: Heading for New Processes,
Springer, Berlin etc., 1995

[29]

Österle, H., Enterprise in the Information Age, in: Österle, H., Fleisch, E., Alt, R.,
Business Networking: Shaping Collaboration Between Companies, Springer,
Berlin etc., 2001, pp. 17-53

[30]

Perry, M.L., Pearce, C.L., Sims, H.P., Empowered Selling Teams: How Shared
Leadership Can Contribute to Selling Team Outcomes, in: Journal of Personal
Selling & Sales Management, 19 (1999) 3, pp. 35-51

[31]

Porter, M.E., Strategy and the Internet, in: Harvard Business Review, 79 (2001)
3, pp. 63-78

[32]

Raghupathi, W., Tan, J., Strategic IT Application in Health Care, in:
Communications of the ACM, 45 (2002) 12, pp. 56-61

[33]

Rigby, D.K., Reichheld, F.F., Schefter, P., Avoid the Four Perils of CRM, in:
Harvard Business Review, 80 (2002) 2, pp. 101-109

[34]

Scharitzer, D., Kollarits, H.C., Satisfied Customers: Profitable Customer
Relationships: Pharmaceutical Marketing: How Pharmaceutical Sales
Representatives Can Achieve Economic Success Through Relationship
Management with Settled General Practitioners - An Empirical Study, in: Total
Quality Management, 11 (2000) 7, pp. 955-965

[35]

Sellers, L.J., Pharma's Quantum Shuffle, in: Pharmaceutical Executive, 21 (2001)
8, pp. 70
537

Rainer Alt

[36]

Shankaranarayan, G., Balusubramanian, P.R., Kang, C., Conceptualizing
Architectures for E-Business Systems, in: Chung, M. (Ed.), Proceedings 6.
Americas Conference on Information Systems, Long Beach (CA), 2000, pp. 249252

[37]

Spain, J.W., Siegel, C.F., Ramsey, R.P., Selling Drugs Online: Distributionrelated Legal/ Regulatory Issues, in: International Marketing Review, 18 (2001)
4, pp. 432-449

[38]

Whyte, W.F., Participatory Action Research, Sage Publications, Newbury Park
etc., 1991

[39]

Wilson, H., Daniel, E., McDonald, M., Factors for Success in Customer
Relationship Management (CRM) Systems, in: Journal of Marketing
Management, 18 (2002) 1/2, pp. 193-219

[40]

Winer, R.S., A Framework for Customer Relationship Management, in:
California Management Review, 43 (2001) 4, pp. 89-105

[41]

Xu, Y., Yen, D.C., Lin, B., Chou, D.C., Adopting Customer Relationship
Management Technology, in: Industrial Management & Data Systems, 102
(2002) 8, pp. 442-452

[42]

Yu, L., Successful Customer-Relationship Management, in: MIT Sloan
Management Review, 42 (2001) 4, pp. 18-19

[43]

Zabada, C., Singh, S., Munchus, G., The Role of Information Technology in
Enhancing Patient Satisfaction, in: British Journal of Clinical Governance, 6
(2001) 1, pp. 9-16

[44]

Zeng, M., Liu, L.C., Koong, K.S., An Examination of Selected Medical Website
Quality, in: Dhana, K.M., Hunter, G.M. (Eds.), Proceedings ISOneWorld
Conference, Information Institute, Las Vegas (NV), 2003

538

